康妇消炎栓治疗慢性盆腔炎60例的临床研究

Clinical Study on 60 Cases of Chronic Pelvic Inflammation Treated With Kangfu Xiaoyan Suppository

目的分析、研究康妇消炎栓联合左氧氟沙星和金刚藤片治疗慢性盆腔炎的临床疗效。方法选取我院2015年4月—2018年2月收治的慢性盆腔炎患者120例作为研究对象,采用随机数字法进行分组。其中,60例患者接受左氧氟沙星和金刚藤片治疗,将其作为对照组;另60例患者接受康妇消炎栓联合左氧氟沙星和金刚藤片治疗,将其作为研究组,观察、比较两组患者的治疗效果。结果研究组患者的治疗总有效率为91.67%,高于对照组的55.00%,组间数据比较,差异具有统计学意义(P<0.05)。治疗前,比较两组患者的盆腔积液深度、包块直径,差异无统计学意义(P>0.05);治疗后,研究组盆腔积液深度、包块直径均低于对照组,组间数据比较,差异具有统计学意义(P<0.05)。治疗前,比较两组患者的T淋巴细胞亚群指标,差异无统计学意义(P>0.05);治疗后,研究组CD4^+/CD8^+、CD8^+、CD4^+、CD3^+高于对照组,组间数据比较,差异具有统计学意义(P<0.05)。结论左氧氟沙星和金刚藤片治疗慢性盆腔炎的基础上,再给予康妇消炎栓,可更好的调节患者免疫功能和改善疾病症状,安全性高。

Objective To analyze the clinical efficacy of kangfu xiaoyan suppository combined with levofloxacin and jingangteng tablets in the treatment of chronic pelvic inflammatory disease. Methods 120 patients with chronic pelvic inflammatory disease admitted to our hospital from April 2015 to February 2018 were selected as the study subjects. Random number method was used for grouping. Among them, 60 patients received levofloxacin and jingangteng tablets as control group. Another 60 patients were treated with kangfu xiaoyan suppository combined with levofloxacin and jingangteng tablets as study group. To observe and compare the therapeutic effect of two groups of patients. Results The total effective rate was 91.67% in the study group, higher than 55.00% in the control group. There was a significant difference between the two groups (P<0.05). Before treatment, there was no significant difference in the depth of pelvic effusion and the diameter of pelvic mass between the two groups (P>0.05). After treatment, the depth of pelvic effusion and the diameter of pelvic mass in the study group were lower than those in the control group, and the difference between the two groups was statistically significant (P<0.05). Before treatment, there was no significant difference in T lymphocyte subsets between the two groups (P > 0.05). After treatment, the levels of CD4^+/CD8^+, CD8^+, CD4^+, CD3^+ in the study group were higher than those in the control group, and the difference was statistically significant (P<0.05). Conclusion On the basis of treatment of chronic pelvic inflammatory disease with levofloxacin and jingangteng tablets, kangfu xiaoyan suppository can better regulate the immune function of patients and improve the symptoms of the disease.